During the past decade, Sacramento Heart and Vascular Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sacramento Heart and Vascular Research Center" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Abbott" with 1 trials sponsored, "Accumetrics, Inc." with 1 trials sponsored, "Allon Therapeutics" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacramento Heart and Vascular Research Center" #1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sacramento Heart and Vascular Research Center" are "Type 2 Diabetes Mellitus" (3 trials), "Atrial Fibrillation" (2 trials), "Hypertension" (2 trials), "Intermittent Claudication" (2 trials) and "Peripheral Vascular Disease" (2 trials). Many other conditions were trialed in "Sacramento Heart and Vascular Research Center" in a lesser frequency.

Most popular intervention types in "Sacramento Heart and Vascular Research Center" are "Drug" (14 trials), "Behavioral" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ranolazine" (3 trials), "Darusentan" (2 trials), "Diet" (2 trials) and "Exercise" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sacramento Heart and Vascular Research Center" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Sacramento Heart and Vascular Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Sacramento Heart and Vascular Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sacramento Heart and Vascular Research Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".